about
Asymptomatic hyperuricemia is not an independent risk factor for cardiovascular events or overall mortality in the general population of the Busselton Health Study.Rheumatoid factors do not predict cardiovascular disease and mortality in the general population in the Busselton Health Survey.IL-17A levels in systemic lupus erythematosus associated with inflammatory markers and lower rates of malignancy and heart damage: Evidence for a dual role.Increased von Willebrand factor levels in patients with systemic lupus erythematosus reflect inflammation rather than increased propensity for platelet activation.Higher Charlson Comorbidity Index scores do not influence Functional Independence Measure score gains in older rehabilitation patients.Insulin-like growth factor-1 (IGF1) in systemic lupus erythematosus: relation to disease activity, organ damage and immunological findings.A multicentre observational study comparing patient reported outcomes to assess reliability of swollen and tender joint assessments and response to certolizumab treatment as compared to clinician assessments in rheumatoid arthritisImplementation of the Western Australian Osteoporosis Model of Care: a fracture liaison service utilising emergency department information systems to identify patients with fragility fracture to improve current practice and reduce re-fracture rates:Hospitalisation rates and characteristics for adult and childhood IgA vasculitis in Western AustraliaHypocomplementemia as a Risk Factor for Organ Damage Accrual in Patients with Systemic Lupus ErythematosusThe burden of subclinical intra-articular inflammation in goutPrincipal component analysis reveals disconnect between regulatory cytokines and disease activity in Systemic Lupus ErythematosusPregnancy outcomes in women with a history of immunoglobulin A vasculitisThe current role for clinical and renal histological findings as predictor for outcome in Australian patients with lupus nephritisThe importance of tubuloreticular inclusions in lupus nephritisPrognostication accuracy of final destination in poststroke patients requiring transitional careRehabilitation Indices associated with sustaining a minimal trauma fracture within 12 months of a stroke in Western AustraliaAssociation of Achieving Lupus Low Disease Activity State Fifty Percent of the Time With Both Reduced Damage Accrual and Mortality in Patients With Systemic Lupus ErythematosusInfection Rates Before and After Diagnosis of IgA Vasculitis in Childhood: A Population-wide Study Using Non-exposed Matched ControlsThe Impact of Cytokines on the Health-Related Quality of Life in Patients with Systemic Lupus Erythematosus
P50
Q36225590-F856790E-2046-45E7-8BAD-F2780C49744DQ36383052-D508F950-872B-4FED-B3D2-77EEB202B7A2Q37679294-041D630B-618B-4693-96B3-0D0F4DB3B089Q39367860-93BDDDD0-A989-42C7-BB55-BF68113681A7Q39402814-31F16BE1-0683-4F89-99F0-820C92986FBEQ49549054-49B2E2D2-6C46-44A4-B3A7-6E4195912FFFQ58608867-2D2EAC49-72A4-4C96-965A-4510C9638D7DQ58608872-506AB598-DC68-4B4A-A17A-3A4BEEB13635Q58608876-966D45A2-6689-4A16-95A6-2B47A65C3901Q61453809-1FA66BC7-D055-4A82-8165-3FA51009613BQ89929130-AD0DEE6E-9EB7-4422-AF41-5B86204F34C1Q90520162-48906678-FBC4-4F20-B2D1-B360B24F3445Q90781028-2FFE21DD-9B24-4363-AC53-C4059C1D198AQ90856365-058617A4-7BEB-4DF6-AE05-2998C1C11BF2Q91023460-AB1CEA55-CD8E-42BF-9BDA-63C95BBE16DFQ91337097-1730C96D-6C79-4663-AFA6-0F3BFF96FCC4Q91919641-1FCAFA33-E496-45A0-A387-467524D95842Q92037992-6D2FDF05-C141-4DC1-B22F-ED4B2F4B7B60Q92774343-D07A7D6C-6B98-4355-A5F3-C0AE02928AABQ92816495-1685E45D-434C-4915-BE71-7BBF04C061BB
P50
description
investigador
@es
researcher
@en
name
W Raymond
@en
type
label
W Raymond
@en
prefLabel
W Raymond
@en
P31
P496
0000-0002-2537-0070